在大脑微环境中通过细胞外囊介导的黄素输送进行工程设计,调节 lysosomes,线粒体和微细胞重编程,用于帕金森病治疗
Ming-You Shie1,2,3,4, Mei-Chih Chen5,6, Yeh Chen7
1Department of Biomedical Engineering, China Medical University, Taichung, 406040, Taiwan. eric@mail.cmu.edu.tw.
Journal of nanobiotechnology
|December 13, 2025
概括
这项研究开发了针对帕金森病治疗的向纳米粒子. 这些纳米颗粒有效地向大脑输送黄素,改善运动功能并保护帕金森病模型中的神经元.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和α-synuclein聚合.
- 黄素显示神经保护的潜力,但遭受了贫穷的生物利用性和大脑透.
- 现有的药物输送方法在向受PD影响的特定大脑区域时面临挑战.
研究的目的:
- 开发一种基于细胞外囊泡 (EV) 的新型药物输送系统,用于精确地将黄素输送到PD中的多巴胺基神经元.
- 为了克服黄素的药理动力学限制,有效治疗PD.
- 在PD模型中评估加载黄素的DAT向EVs的治疗疗效.
主要方法:
- 设计HEK293T细胞以产生显示DAT准scFv片段的EV.
- 封装的黄素变成了针对DAT的EV (Cur@αDAT EVs).
- 在PD细胞模型中评估了EV吸收,α-Syn积累和蛋白质表达.
- 在6-OHDA诱导的PD大鼠模型中评估了运动和认知功能,神经保护和神经炎症.
主要成果:
- 在PD细胞模型中,Cur@αDAT EVs在多巴胺基神经元中显示出显著的吸收.
- 治疗减少了α-Syn聚合,并恢复了DJ-1,TH和PARKIN的表达.
- 在PD大鼠中,Cur@αDAT EVs改善了运动和认知功能,并保护了多巴胺基神经元.
- 在黑体和腹膜区域确认了精确的黄素积累,验证了有针对性的输送.
结论:
- 针对DAT的电动汽车为帕金森病的精确药物输送提供了一个有前途的平台.
- 这种方法有效地克服了黄素的生物可用性和血脑屏障的挑战.
- 开发的系统为PD等神经退行性疾病提供了潜在的治疗策略.
更多相关视频
07:55Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024
784
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
7.2K
相关概念视频
01:24Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:21EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K